<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-07-02 22:02:47H. Lee Moffitt Cancer Center & Research Institute Albert Einstein College of Medicine Sanford-Burnham Medical Research Institute Friends of Cancer Research University of Texas MD Anderson Cancer Center National Institutes of Health Ellen V. Sigal James L. Gulley Barbara Ann Karmanos Cancer Institute Medicine Cancer organizations Oncology |
Add to Reading List |
Microsoft Word - Signature | MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and developmentDocID: 15NcO - View Document |
| Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-basedDocID: 15MxD - View Document |
| Microsoft Word - ScientificLeadershipBiosFinal042409.docDocID: 14qIu - View Document |
| Published in June[removed]Clinical Trial Solutions Copyright 2014 by PharmaLinx LLCDocID: P6St - View Document |
| restifo-CD8_TcellDiff_v02DocID: GAsV - View Document |